Sandoz-Oxazepam 15 Namibia - English - Namibia Medicines Regulatory Council

sandoz-oxazepam 15

sandoz (sa) (pty) ltd - oxazepam - tablet - oxazepam 15mg

Sandoz-Oxazepam 30 Namibia - English - Namibia Medicines Regulatory Council

sandoz-oxazepam 30

sandoz (sa) (pty) ltd - oxazepam - tablet - oxazepam 30mg

OXAZEPAM MYLAN oxazepam 30mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

oxazepam mylan oxazepam 30mg tablet bottle

bafna pharmaceuticals pty ltd - oxazepam, quantity: 30 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; quinoline yellow; maize starch; erythrosine - indications as at 25 january 2005 : oxazepam mylan is indicated for: management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety associated with depression is also responsive to oxazepam therapy. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the physician should periodically reassess the usefulness of the drug for the individual patient. alcoholics with acute tremulousness, confusional state or anxiety associated with alcohol withdrawal are responsive to therapy.

OXAZEPAM MYLAN oxazepam 15mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

oxazepam mylan oxazepam 15mg tablet bottle

bafna pharmaceuticals pty ltd - oxazepam, quantity: 15 mg - tablet, uncoated - excipient ingredients: magnesium stearate; erythrosine; maize starch; quinoline yellow; lactose monohydrate - indications as at 25 january 2005 : oxazepam mylan is indicated for: management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety associated with depression is also responsive to oxazepam therapy. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the physician should periodically reassess the usefulness of the drug for the individual patient. alcoholics with acute tremulousness, confusional state or anxiety associated with alcohol withdrawal are responsive to therapy.